Aneuploidy Rate and Stimulation Protocol: Recombinant Follicle Stimulating Hormone (FSH) Versus Human FSH

Not Applicable

Terminated

• Conditions: Aneuploidy Rate

• Registration Number: NCT01164943
• Lead Sponsor: IVI Madrid

Brief Summary

Several stimulation protocols have been used in in vitro fertilization (IVF) in a cycle of egg donation; recombinant FSH and human FSH are included. The effect of each kind of hormone on aneuploidy rate it is unknown. If there was an increase on aneuploidy rate of one of these stimulation protocols, there will be a negative effect on the successful rates in the egg donation cycles. The aim of this study is to observe if there is a different in aneuploidy rate and morphological oocyte parameters between different stimulation protocols.

Detailed Description

Not available

Study Timeline

• Study Start: 2010-07
• Study First Submitted: 2010-07-16
• Study First Submitted QC: 2010-07-16
• Study First Posted: 2010-07-19
• Primary Completion: 2012-12
• Study Completion: 2012-12
• Status Verified: 2015-04
• Last Update Submitted: 2016-02-24
• Last Update Posted: 2016-02-25

Recruitment & Eligibility

• Status: TERMINATED
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

• Egg donation cycles with more than 8MII in oocyte retrieval day

Exclusion Criteria

• Male factor
• Uterine malformations
• genetic alterations

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Aneuploidy Rate	2011 January	Analysis of all nuclei fixed

Secondary Outcome Measures

Name	Time	Method
Outcome rates (implantation, pregnancy and miscarriage rate)	2011 April	Time requierd to know all the implantation, pregnancy and miscarriage rate
Oocyte morphology	2011 january	Analysis of all oocytes

Trial Locations

Locations (1)

Insituto Valenciano de Infertilida, Spain, Madrid; 🇪🇸 Madrid, Spain